SOPs for Biosimilars V 2.0

To define the standard procedure for assessing the genetic stability of biosimilar-producing cell lines through molecular and expression-level analyses to ensure consistent gene integration, copy number, and protein expression over multiple passages.
Click to read the full article.

To establish a uniform and traceable procedure for the archival and inventory management of biosimilar-producing clones, ensuring secure storage, proper labeling, and ease of retrieval for future use in compliance with data integrity and GMP principles.
Click to read the full article.

To define the procedure for routine monitoring and control of microbial contamination in biosimilar R&D environments, including clean areas, cell culture labs, and equipment, to ensure sterility, safety, and compliance with GMP guidelines.
Click to read the full article.

To define the procedure for the periodic calibration of incubators used in biosimilar R&D for maintaining required environmental conditions (temperature and CO₂ concentration) to support viable and reproducible cell growth.
Click to read the full article.

To outline the routine procedure for monitoring and verifying carbon dioxide (CO₂) concentrations in cell culture incubators used in biosimilar development, ensuring optimal atmospheric conditions for cell growth and viability.
Click to read the full article.

To establish standardized procedures for the safe use, routine cleaning, and maintenance of biosafety cabinets (BSCs) used in biosimilar R&D and manufacturing areas, ensuring aseptic processing and operator protection from biological hazards.
Click to read the full article.

To describe the procedure for routine cleaning and decontamination of cell culture laboratories used in biosimilar development to maintain aseptic processing conditions and prevent microbial or cross-contamination.
Click to read the full article.

To define the standardized procedure for the safe handling, segregation, treatment, and disposal of biohazardous waste generated during biosimilar cell culture operations in compliance with applicable biosafety and biomedical waste regulations.
Click to read the full article.

To establish a standardized system for documentation of clone selection, screening data, and related results to ensure data traceability, compliance, and reproducibility in biosimilar cell line development.
Click to read the full article.

To outline a systematic process for identifying, documenting, investigating, and resolving deviations encountered during clone development activities in biosimilar manufacturing, ensuring compliance with GMP and data integrity standards.
Click to read the full article.